Advertisement
Canada markets close in 3 hours 57 minutes
  • S&P/TSX

    22,188.05
    +80.97 (+0.37%)
     
  • S&P 500

    5,253.78
    +5.29 (+0.10%)
     
  • DOW

    39,783.69
    +23.61 (+0.06%)
     
  • CAD/USD

    0.7389
    +0.0016 (+0.22%)
     
  • CRUDE OIL

    82.67
    +1.32 (+1.62%)
     
  • Bitcoin CAD

    96,492.98
    +3,019.88 (+3.23%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,234.20
    +21.50 (+0.97%)
     
  • RUSSELL 2000

    2,132.46
    +18.11 (+0.86%)
     
  • 10-Yr Bond

    4.1870
    -0.0090 (-0.21%)
     
  • NASDAQ

    16,401.42
    +1.90 (+0.01%)
     
  • VOLATILITY

    12.89
    +0.11 (+0.86%)
     
  • FTSE

    7,964.40
    +32.42 (+0.41%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • CAD/EUR

    0.6839
    +0.0034 (+0.50%)
     

BioteQ Expands Patent Portfolio With Issuance of Two New Patents and PCT Filing

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct. 7, 2014) - BioteQ Environmental Technologies Inc. (BQE.TO), a leader in the treatment of mine impacted waters, has expanded its patent portfolio with the issuance of two new patents from the U.S. Patent and Trademark Office for the company's proprietary nickel sulphide precipitation and sulphate removal processes, and its filing of a Patent Cooperation Treaty (PCT) for the company's Selen-IX™ process.

BioteQ's proprietary nickel sulphide precipitation process, U.S. patent No. 8,747,678 B2, relates to processes to selectively remove nickel from mine impacted waters. BioteQ currently uses the process at its water treatment facility in northern Quebec.

BioteQ's proprietary sulphate removal process, U.S. patent No. 8,551,340 B2, relates to processes to selectively remove sulphate from hard water waste streams. This process has been used in various testing and piloting projects to date.

BioteQ has also filed application # PCT/CA2014/05096 under the PCT for its Selen-IX™ technology to selectively remove selenium from mine impacted waters and potentially other industrial waste streams. This international filing provides BioteQ with protection for the technology in 148 countries throughout the world and follows the filing of the US provisional patent application in October 2013 which established the invention priority date with the U.S. Patent and Trademark Office. Since the filing of the US provisional application in 2013, the Selen-IX™ technology has been deployed in two pilot scale operations, first with a Canadian metals and mining company in 2013 and currently with another Canadian mining company. The filing of the PCT application enables BioteQ to engage in commercial promotion of the Selen-IX™ technology worldwide while immediately enjoying the protection of its unique intellectual property under the PCT.

ADVERTISEMENT

"With the issuing of these two new patents and the filing of the PCT application, we have strengthened the patent portfolio for our suite of technologies," said BioteQ President & Interim CEO, David Kratochvil. "These patents and the filing will support our business development efforts by emphasizing our commitment and capabilities in technology development in strategic areas of the overall mine water treatment market."

BioteQ Corporate Profile

BioteQ is an innovative clean technology leader in global mine water treatment, serving the mining, metal smelting, refining and hydrometallurgical sectors. The company has commercially proven patented technologies and operational capabilities to help customers achieve compliance with stringent regulations cost effectively while minimizing waste and maximizing water recovery. Over the past decade, BioteQ has designed and commissioned plants at mine sites for leading organizations including Glencore-Xstrata, Freeport McMoRan, Jiangxi Copper and the US EPA and is currently operating six plants under long-term contracts. These plants remove dissolved metals and sulphate to well below the required regulatory discharge limits while reducing or eliminating the production of waste sludge and/or recovering valuable metals from waste streams for sale which reduces the life cycle cost of water treatment. BioteQ is headquartered in Vancouver, Canada and trades on the TSX under the symbol BQE. Please visit our website at www.bioteq.ca for additional information.

The Toronto Stock Exchange has not reviewed and does not accept responsibility for the adequacy or the accuracy of this release.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

Certain information contained herein may not be based on historical fact and therefore constitutes "forward-looking information" under applicable Canadian securities legislation. This includes without limitation statements containing the words "plan", "expect", "project", "estimate", "intend", "believe", "anticipate", "may", "will" and other similar words or expressions. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks, uncertainties and other factors that may cause actual events or results to differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the Company's dependence on key personnel and contracts, uncertainty with respect to the profitability of the Company's technologies, competition, technology risk, the Company's ability to protect its intellectual property and proprietary information, fluctuations in commodity prices, currency risk, environmental regulation and the Company's ability to manage growth and other factors described in the Company's filings with the Canadian securities regulators at www.sedar.com (including without limitation the factors described in the section entitled "Risks and Uncertainties" in the Company's Annual Report for the year ended December 31, 2013 and the section entitled "Risk Factors" in the Company's Annual Information Form for the year ended December 31, 2013). Given these risks and uncertainties, the reader is cautioned not to place undue reliance on forward-looking statements. All forward-looking information contained herein is based on management's current expectations and the Company undertakes no obligation to revise or update such forward-looking information to reflect subsequent events or circumstances, except as required by law.